Fly News Breaks for February 22, 2018
Feb 22, 2018 | 10:16 EDT
Stifel analyst Michael Hoffman reiterated his Buy rating on Stericycle following the company's Q4 report, noting its sales beat and "slight" EPS miss. The company's conventional free cash flow "remains sound" with a five year CAGR forecast of over 10%, added Hoffman, who maintains his $90 price target on Stericycle shares, which are down 16.5% to $62.50 in early trading.
News For SRCL From the Last 2 Days
There are no results for your query SRCL